Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |